As in Figure 3D, the expression levels of monocyte-related cytokines or chemokines also increased in the plasma of patients with IIM, including IL-8 (5.72 ± 2.15 vs. 4.28 ± 0.96, p < 0.0001), CSF-1 (9.30 ± 0.38 vs. 8.93 ± 0.23, p = 0.0001), IL-6 (3.78 ± 1.53 vs. 2.31 ± 0.43, p < 0.0001), CCL3 (6.73 ± 0.88 vs. 5.49 ± 0.57, p < 0.0001), TNF (3.86 ± 0.45 vs. 3.09 ± 0.28, p < 0.0001), MCP-1 (13.06 ± 0.84 vs. 11.45 ± 0.48, p < 0.0001), MCP-2 (11.43 ± 1.10 vs. 9.67 ± 1.06, p < 0.0001), and MCP-3 (4.27 ± 1.59 vs. 1.04 ± 0.64, p < 0.0001). The gene discussed is CCL2; the disease is acquired idiopathic inflammatory myopathy.